Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.lfs.2004.10.051
Title: Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats
Authors: Tan, B.K.H. 
Tan, C.H. 
Pushparaj, P.N. 
Keywords: Averrhoa bilimbi
Cytochrome P450
Hepatic glycogen
High fat diet
Sprague-Dawley rats
Streptozotocin
Thiobarbituric acid reactive substances
Issue Date: 2005
Source: Tan, B.K.H., Tan, C.H., Pushparaj, P.N. (2005). Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sciences 76 (24) : 2827-2839. ScholarBank@NUS Repository. https://doi.org/10.1016/j.lfs.2004.10.051
Abstract: The present study was designed to investigate the hypoglycemic and hypolipidemic activities of the semi-purified fractions of an ethanolic leaf extract of Averrhoa bilimbi (ABe) in high fat diet (HFD)-streptozotocin (STZ)-induced diabetic rats. Male Sprague-Dawley rats aged 10 weeks (200-250 g) were fed with a high fat diet obtained from Glen Forrest stock feeders (Western Australia) for 2 weeks prior to intraperitoneal injection with streptozotocin (STZ, 50 mg/kg). The leaves of A.bilimbi were exhaustively extracted with 80% ethanol, concentrated at 40°C using a rotavapor and partitioned successively with butanol, ethylacetate and hexane to get aqueous (AF), butanol (BuF), ethylacetate (EF), and hexane fractions (HF). The fractions were freeze-dried to obtain powders of each. To investigate the effect of long term administration of the hypoglycemic fractions, diabetic animals were treated with vehicle (distilled water), AF (125 mg/kg), or BuF (125 mg/kg), twice a day for 14 days. The long term administration of AF and BuF at a dose of 125 mg/kg significantly (P < 0.05) lowered blood glucose and triglyceride concentrations when compared to the vehicle. The hepatic glycogen content was significantly higher (P < 0.05) in AF-treated rats when compared to diabetic control, however no change was found in the BuF-treated rats. Moreover, AF as well as BuF did not cause any significant change in the total cholesterol and HDL-cholesterol. There was also no difference in liver thiobarbituric acid reactive substances (TBARS) and cytochrome P450 values between AF, BuF and vehicle-treated control rats. In conclusion, the results indicate that AF is more potent than BuF in the amelioration of hyperglycemia and hyperlipidemia in HFD fed-STZ diabetic rats. Hence, AF is a potential source for the isolation of active principle (s) for oral anti-diabetic therapy. © 2005 Elsevier Inc. All rights reserved.
Source Title: Life Sciences
URI: http://scholarbank.nus.edu.sg/handle/10635/29694
ISSN: 00243205
DOI: 10.1016/j.lfs.2004.10.051
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

71
checked on Dec 7, 2017

WEB OF SCIENCETM
Citations

55
checked on Nov 29, 2017

Page view(s)

211
checked on Dec 11, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.